Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in Children

Documenti analoghi

• Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension
  di: Justin J. Kochanski, et al.
  Pubblicazione: (2024)
• Association of Immunoglobulin E With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
  di: Fengxia Wu, et al.
  Pubblicazione: (2026)
• Early Experience of Treprostinil Dry‐Powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Tertiary Referral Center
  di: Jordin L. Rice, et al.
  Pubblicazione: (2026)
• An Unsupervised Approach to Derive Right Ventricular Pressure–Volume Loop Phenotypes in Pulmonary Hypertension
  di: Nikita Sivakumar, et al.
  Pubblicazione: (2025)
• Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension
  di: Daniel J. Lachant, et al.
  Pubblicazione: (2025)